Please find attached herewith report for the month of December, 2025 pertaining to re-lodgements of transfer of Physical Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has submitted its December 2025 monthly report on the re-lodgement of physical share transfer requests, as required under the SEBI circular dated July 2, 2025, which created a special window for re-submitting old physical share transfers that were rejected or not processed before the April 1, 2019 deadline. According to the Registrar (Beetal Financial & Computer Services), the company received 2 transfer requests in December 2025. Both requests were processed, but neither was approved — all 2 were rejected, with an average processing time of 20 days. The filing is a routine regulatory compliance update submitted to BSE and does not involve any new business activity.
No material impact on shareholders or the stock price. This is a routine monthly compliance report about an administrative process for old physical share transfers, with both re-lodged requests rejected in this period.